Restricted accessLetterFirst published online 2025-04
Comment on: “Duration of Bare Sclera Pterygium Surgery Combined with Mitomycin C with and Without Tranexamic Acid: A Randomized Double-Blind Controlled Trial”
KovalisN, GraffiS, SafuriS, et al.Duration of bare sclera pterygium surgery combined with Mitomycin C with and without tranexamic acid: A randomized double-blind controlled trial. J Ocul Pharmacol Ther, 2024; 40(10):675–679; doi: 10.1089/jop.2024.0068
2.
ColominaMJ, ContrerasL, GuilabertP, et al.Clinical use of tranexamic acid: Evidences and controversies. Braz J Anesthesiol, 2022; 72(6):795–812; doi: 10.1016/j.bjane.2021.08.022
3.
HosseiniH, NejabatM, KhaliliMR. Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia. Med Hypotheses, 2007; 69(4):925–927; doi: 10.1016/j.mehy.2007.01.047
4.
MansourAM. Treatment of inflamed pterygia or residual pterygial bed. Br J Ophthalmol, 2009; 93(7):864–865; doi: 10.1136/bjo.2008.155291
